Table 1.
Some features associated with polypharmaceutical UK hospital admissions.
| Medicine Measures | Risk Rate | Consequence | Treatment Duration (Months) | Age (Years) |
|---|---|---|---|---|
| 2 or more medicines with moderate | 97 | Confusion | N/A | >18 |
| or high anticholinergic activity | 8 | Fracture | ||
| 1 or more medicines for dementia + 1 or more medicines with moderate or high | 316 | Confusion | N/A | >18 |
| anticholinergic activity | 53 | Fracture | ||
| NSAID + RAS + diuretic | 16 | Kidney Injury | N/A | >18 |
| Z-drug for more than one month | 162 | Fall | > 1 | >65 |
| 28 | Fracture | |||
| benzodiazepine for more than one month | 181 | Fall | > 1 | >65 |
| 32 | Fracture | |||
| benzodiazepine and Z-drug (not concurrently) | 212 | Fall | >1 | >65 |
| for more than one month | 35 | Fracture | ||
| NSAID without gastro-protection | 9 | bleed | N/A | >65 |
| NSAID + oral anticoagulant | 33 | bleed | N/A | >18 |
| oral anticoagulant + anti-platelet without gastro-protection | 31 | bleed | N/A | >18 |
| aspirin + anti-platelet without gastro-protection | 20 | bleed | N/A | >18 |
| oral or transdermal opioid without a laxative | 8 | constipation | N/A | >18 |
| oral or transdermal opioid for more than three months | 18 | respiratory depression, overdose poisoning or confusion | >3 | >18 |
| inhaled Long Acting Beta-agonist (LABA) without an inhaled corticosteroid (ICS) | 9 | exacerbation of asthma | N/A | N/A |